CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


28-June-2011
Cerilliant Introduces New Stable Labeled Internal Standard of Duloxetine-D3 HCl

Duloxetine-D3 HCl, 100 µg/mL D-068
100 ug/mL (as free base) in Methanol

A stable-labeled internal standard suitable for numerous GC/MS and LC/MS applications from clinical toxicology and urine drug testing to forensic analysis and isotope dilution methods. Duloxetine, marketed in the US under the trade name Cymbalta®, is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder and to alleviate pain associated with diabetic neuropathy, fibromyalgia, and osteoarthritis.

Cerilliant offers certified solution standards for a wide variety of SNRI drugs from other pain management pharmaceuticals such as milnacipran and the antidepressant venlafaxine to the antihistamines chlorpheniramine and brompheniramine.


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn